Vivo Opportunity, LLC's Net Worth

$0

Estimate Recalculated Sep 17, 2024 11:50PM EST

Who is Vivo Opportunity, LLC

Vivo Opportunity, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., Crinetics Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, Kadmon Holdings, Inc., Bolt Biotherapeutics, Inc., Terns Pharmaceuticals, Inc., SOLENO THERAPEUTICS INC, and IO Biotech, Inc..

SEC CIK

Vivo Opportunity, LLC's CIK is 0001728970

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Crinetics Pharmaceuticals, Inc.

Investor
Updated Mar 11, 2020
Form 4
-0.02%
-528.00
$19.50
-$10.30K
Mar 11, 2020
3.27M
Sale
Mar 09
Form 4
-0.21%
-13.46K
$21.70
-$291.59K
Feb 11, 2020
6.54M
Sale
Feb 07 - Feb 10
Form 4
-0.41%
-13.46K
$22.80
-$306.89K
Feb 06, 2020
3.28M
Sale
Feb 04
Form 4
-0.27%
-26.92K
$22.00
-$594.16K
Jan 31, 2020
9.90M
Sale
Jan 29 - Jan 31
Form 4
-11.16%
-417.00K
$22.25
-$9.28M
Mar 25, 2019
3.32M
Sale
Mar 20
Form 4
-42.43%
-7.40M
$17.65
$6.58M
Jul 20, 2018
10.04M
Buy-Options
Jul 20
Showing 6 results

Terns Pharmaceuticals, Inc.

Investor
Updated Apr 03, 2024
Form 4
-6.32%
-420.66K
$6.65
-$2.80M
Apr 03, 2024
6.24M
Sale
ScheduledApr 01 - Apr 03
Form 4
21.18%
758.62K
$7.25
$5.50M
Dec 23, 2022
6.66M
Purchase
Dec 23
Form 4
20.12%
600.00K
$3.60
$2.16M
Sep 08, 2022
5.90M
Purchase
Sep 07
Form 4
224.42%
4.12M
$2.56
$10.61M
Aug 16, 2022
8.28M
Purchase
Aug 12 - Aug 16
Form 4
118.18%
1.45M
$17.00
$6.08M
Feb 09, 2021
2.68M
Purchase
Feb 09
Showing 5 results

Kadmon Holdings, Inc.

Investor
Updated Jan 08, 2019
Form 3
Jan 08, 2019
12.61M
Showing 1 results

Bolt Biotherapeutics, Inc.

Investor
Updated Nov 22, 2023
Form 4
-0.15%
-3.40K
$0.90
-$3.06K
Nov 22, 2023
3.78M
Sale
Nov 21
Form 4
-1.35%
-86.05K
$0.93
-$79.93K
Nov 20, 2023
7.76M
Sale
Nov 16 - Nov 20
Form 4
9.93%
349.77K
$16.57
$3.00M
Feb 09, 2021
3.87M
Purchase
Feb 09
Showing 3 results

Sierra Oncology, Inc.

Investor
Updated Jul 01, 2022
Form 4
-100.00%
-5.19M
$55.00
-$183.12M
Jul 01, 2022
Disposition
Jul 01
Form 4
41.33%
800.00K
$27.00
$21.60M
Jan 31, 2022
3.33M
Purchase
Jan 31
Form 4
-32.96%
-1.24M
$13.20
-$16.41M
Jan 28, 2022
2.53M
Options
Jan 26
Form 4
2,143.35%
1.83M
Jan 31, 2020
1.92M
Options
Jan 29
Form 3
Dec 02, 2019
2.44M
Showing 5 results

ALX ONCOLOGY HOLDINGS INC

Investor
Updated Jul 21, 2020
Form 4
33.59%
1.06M
$19.00
$3.52M
Jul 21, 2020
4.22M
Purchase
Jul 21
Showing 1 results

SOLENO THERAPEUTICS INC

Investor
Updated Aug 29, 2024
Form 4
-14.01%
-1.02M
$48.01
-$49.21M
Aug 29, 2024
6.29M
Sale
Aug 27 - Aug 29
Form 4
-13.08%
-1.10M
$46.95
-$51.70M
May 01, 2024
7.32M
Sale
Apr 29 - Apr 30
Form 4
$2.50
$13.04M
Oct 04, 2023
8.42M
Options
Oct 02
Form 4
$1.75
$5.61M
Sep 28, 2023
3.20M
Options
Sep 26
Form 3
May 15, 2023
Showing 5 results

IO Biotech, Inc.

Investor
Updated Aug 10, 2023
Form 4
6.32M
$1.02
$6.39M
Aug 10, 2023
9.33M
Purchase
Aug 09
Showing 1 results